Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia

Leukemia

Volumn 12, Issue 4, 1998, Pages 486-492

  Kitagawa, M ^a   Yamaguchi, S ^b   Takahashi, M ^b   Tanizawa, T ^b   Hirokawa, K ^a   Kamiyama, R ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bone marrow; Fas; Fas ligand; Immunohistochemistry; Myelodysplastic syndromes; RT PCR

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GLYCOPHORIN A; LEUKOCYTE ELASTASE; MESSENGER RNA;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; ERYTHROID CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031979845     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400980     Document Type: Article

References (13)

1. Delacretaz F, Schmidt P-M, Piguet D, Bachmann F, Costa J. The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987; 87: 180-186.
2. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 1985; 38: 1202-1217.
3. Kitagawa M, Kamiyama R, Takemura T, Kasuga T. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Arch B 1989; 57: 47-53.
4. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin E, Rifkin S, Alston D, Hernandez B, Shar R, Kaizer H, Gregory S. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol 1996; 63: 265-278.
5. Mundle SD, Venugopal P, Cartlidge JD, Pandav DV, Broady-Robinson L, Gezer S, Robin EL, Rifkin SR, Klein M, Alston DE, Hernandez BM, Rosi D, Alvi S, Shetty VT, Gregory SA, Raza A. Induction of an involvement of interleukin-1β converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood 1996; 88: 2640-2647.
6. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hematopoietic microenvironment. Eur J Hematol 1992; 49: 225-233.
7. Golde DW, Finley TN, Cline MJ. Production of colony-stimulating factor by human macrophages. Lancet 1972; ii: 1397-1399.
8. Pelus LM, Broxmeyer HE, Moore MAS. Regulation of human myelopoiesis by prostaglandin E and lactoferrin. Cell Tissue Kinet 1981; 14: 515-526.
9. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TNF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988; 241: 708-712.
10. Kitagawa M, Kamiyama R, Kasuga T. Increase in number of bone marrow macrophages in patients with myelodysplastic syndromes. Eur J Hematol 1993; 51: 56-58.
11. Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, Tanizawa T, Kamiyama R, Hirokawa K. Overexpression of tumor necrosis factor (TNF)-α and Interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 1997; 11: 2049-2054.
12. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
13. Nagata S. Fas-mediated apoptosis. In: Gupta S, Cohen J (eds). Mechanisms of Lymphocyte Activation and Immune Regulation VI. Plenum Press, New York, 1996, pp 119-124.